Blood test may spot returning throat cancer earlier
NCT ID NCT04696744
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study looked at whether circulating tumor cells (CTCs) in the blood can help predict or detect early return of oropharyngeal cancer. Researchers took blood samples from 12 patients at different times (diagnosis, after treatment, and during follow-up) and analyzed the CTCs. The goal was to see if CTC levels could serve as an early warning sign of relapse, adding to standard imaging and exams.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this approach could provide a simple blood test to catch cancer recurrence earlier in oropharyngeal cancer patients.
- What could go wrong
- This was a very small, early study (12 people) focused on feasibility, not treatment. The technique may not prove reliable enough for routine use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRCULATING TUMOR CELL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Service ORL Chirurgie Cervico-faciale (Pr Philippe CERUSE)
Lyon, 69004, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can less radiation be safer for throat cancer?
- Can a blood filtering technique reveal more about prostate cancer spread?
- Can a simple swab predict who needs less radiation?
- New drug combo aims to shrink oral cancers before surgery
- New drug combo targets HPV-Driven cancers in phase II trial
- Acupuncture timing may be key to preventing dry mouth in head and neck cancer patients